1-5 of 5
ellipticines
Close
Sort by
Journal Articles

Discovery of DNA G-Quadruplexes As a New Target for B-Cell Receptor Signaling Inhibition in Diffuse Large B-Cell Lymphoma

Ying-Zhi Xu, PhD, Thomas Raney, Samantha L. Kendrick, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3502.
https://doi.org/10.1182/blood-2018-99-116793
Published: 2018
Journal Articles

Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia

Anna Eriksson, MD PhD, Albin Osterros, MD, Sadia Hassan, PhD, Joachim Gullbo, MD PhD, Linda Rickardson, PhD, Malin Jarvius, PhD, Peter Nygren, MD Prof., Marten Fryknas, PhD, Martin Hoglund, MD PhD, Rolf Larsson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3609.
https://doi.org/10.1182/blood.V124.21.3609.3609
Published: 2014
Journal Articles

Novel Targeting Of BCL2 and MYC DNA Secondary Structures In Diffuse Large B-Cell Lymphoma (DLBCL)

Samantha L. Kendrick, PhD, Crystal Loftin, BS, Xavier Rivera, Laurence H. Hurley, PhD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2013) 122 (21): 2532.
https://doi.org/10.1182/blood.V122.21.2532.2532
Published: 2013
Journal Articles

NSC 338258 Represents a Novel Anti-Neoplastic Agent for the Treatment of Multiple Myeloma.

Erming Tian, Terry Landowski, Owen Stephens, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Jr.
Journal: Blood
Blood (2006) 108 (11): 3469.
https://doi.org/10.1182/blood.V108.11.3469.3469
Published: 2006
Journal Articles

The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.

Erming Tian, BS, Owen Stephens, BS, Susan Holbeck, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD
Journal: Blood
Blood (2005) 106 (11): 3379.
https://doi.org/10.1182/blood.V106.11.3379.3379
Published: 2005